review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Matteo Bassetti | Q88607142 |
P2093 | author name string | Alessandra Bandera | |
Andrea Gori | |||
P2860 | cites work | Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens | Q28075653 |
The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness | Q28274385 | ||
Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome | Q28821251 | ||
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial | Q34268939 | ||
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation | Q34311369 | ||
Microbiota-mediated colonization resistance against intestinal pathogens | Q34324937 | ||
Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. | Q34691263 | ||
Fecal microbiota transplantation: facts and controversies | Q35044957 | ||
Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report | Q35136477 | ||
Hospitalization Type and Subsequent Severe Sepsis | Q36128633 | ||
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. | Q36198872 | ||
Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of Sepsis | Q36252387 | ||
Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli | Q36559369 | ||
Metagenomic Analysis Reveals Dynamic Changes of Whole Gut Microbiota in the Acute Phase of Intensive Care Unit Patients | Q36922472 | ||
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis | Q37189190 | ||
Effectiveness of Probiotic, Prebiotic, and Synbiotic Therapies in Reducing Postoperative Complications: A Systematic Review and Network Meta-analysis. | Q39285999 | ||
Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis | Q39429041 | ||
Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical Patients | Q39563579 | ||
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens. | Q40063718 | ||
The Intestinal Microbiome in Infectious Diseases: The Clinical Relevance of a Rapidly Emerging Field. | Q40075191 | ||
A randomized synbiotic trial to prevent sepsis among infants in rural India | Q40081393 | ||
Comparative effectiveness of faecal microbiota transplant by route of administration | Q40214260 | ||
Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial | Q40886498 | ||
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. | Q41194710 | ||
Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial | Q42240129 | ||
Bacterial Dissemination to the Brain in Sepsis | Q46242978 | ||
Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection | Q47260522 | ||
Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial | Q47548289 | ||
Risk of Subsequent Sepsis within 90 Days of a Previous Hospital Stay by Type of Antibiotic Exposure | Q47599691 | ||
The microbiome of the critically ill patient | Q47652525 | ||
Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial | Q59128544 | ||
Altered gut microbiota after traumatic splenectomy is associated with endotoxemia | Q59798581 | ||
Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis | Q61804559 | ||
Challenge to the Intestinal Mucosa During Sepsis | Q64078780 | ||
Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial | Q82970230 | ||
Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness | Q90833515 | ||
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial | Q90923666 | ||
The gut microbiome alters immunophenotype and survival from sepsis | Q91887634 | ||
Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiome | Q91943172 | ||
Mice Fed an Obesogenic Western Diet, Administered Antibiotics, and Subjected to a Sterile Surgical Procedure Develop Lethal Septicemia with Multidrug-Resistant Pathobionts | Q92295478 | ||
Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives | Q92556893 | ||
Keeping Candida commensal: how lactobacilli antagonize pathogenicity of Candida albicans in an in vitro gut model | Q92623495 | ||
Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT | Q92946318 | ||
Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review | Q93100771 | ||
P433 | issue | 1 | |
P921 | main subject | sepsis | Q183134 |
P304 | page(s) | 105 | |
P577 | publication date | 2020-03-24 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Therapeutic Potential of the Gut Microbiota in the Management of Sepsis | |
P478 | volume | 24 |
Search more.